PlainPharmaWatch

CMS Open Payments · Tool

Smith+Nephew, Inc. vs US Retina LLC

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

US Retina LLC has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 1,391, versus 151 for the other company. Its single largest recorded recipient represents 0.1% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Smith+Nephew, Inc.
HHI 151 · top recipient 0.1%
Ranked #1,625 of 1,838 companies by HHI
US Retina LLC
HHI 1,391 · top recipient 0.1%
Ranked #899 of 1,838 companies by HHI

Payment Overview

Company A

Smith+Nephew, Inc.

Total Payments
$50.5M
% of Industry
0.4%
Transactions
72,133
Avg per Transaction
$699.79
Recipients
71,450
Avg per Recipient
$706.48
Payment Types
13
Top Payment Type
Royalty or License
Company B

US Retina LLC

Total Payments
$50.8M
% of Industry
0.4%
Transactions
199
Avg per Transaction
$255.3K
Recipients
8
Avg per Recipient
$6.3M
Payment Types
1
Top Payment Type
Acquisitions

Highlighted values indicate the higher figure for each metric.

Total payments compared

Smith+Nephew, Inc. vs US Retina LLC - total reported payments in CMS Open Payments PY2024

US Retina LLC$50.8MSmith+Nephew, Inc.$50.5M

Payment Types Breakdown

Smith+Nephew, Inc.

Royalty or License $24.3M

48.1%

Consulting Fee $7.0M

13.8%

Grant $4.3M

8.5%

Compensation for Services Other Than Consulting $3.6M

7.2%

Travel and Lodging $2.7M

5.3%

Food and Beverage $2.5M

5.0%

US Retina LLC

Acquisitions $355.0K

0.7%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Smith+Nephew, Inc.

  1. 1

    PAUL TORNETTA III

    $3,015,589.80 · 36 txns

  2. 2

    WILLIAM RICCI

    $2,021,396.94 · 42 txns

  3. 3

    ROY SANDERS

    $1,901,786.04 · 28 txns

  4. 4

    LEE KAPLAN

    $1,856,442.81 · 4 txns

  5. 5

    STEVEN B HAAS

    $1,474,916.04 · 181 txns

US Retina LLC

  1. 1

    BENJAMIN BAKALL

    $50,000.00 · 1 txns

  2. 2

    JOSEPH SHEPARD BRYAN

    $50,000.00 · 1 txns

  3. 3

    ALAN J GORDON

    $50,000.00 · 1 txns

  4. 4

    STEPHEN A.M. DE SOUZA

    $50,000.00 · 1 txns

  5. 5

    RAHUL K. REDDY

    $50,000.00 · 1 txns

Summary Comparison

Metric Smith+Nephew, Inc. US Retina LLC
Total Payments $50.5M $50.8M
% of Industry Total 0.4% 0.4%
Transaction Count 72,133 199
Avg per Transaction $699.79 $255.3K
Recipient Count 71,450 8
Avg per Recipient $706.48 $6.3M
Payment Type Count 13 1
Top Payment Type Royalty or License Acquisitions

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.